CAMP MEXC RealStocks
Own real CAMP shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 21:57:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
CAMP4 Therapeutics Corporation (CAMP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.13, with a market capitalization of $271.73M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.90 to $7.75. This page covers its latest market performance, valuation, price trends and company information.
$271.73M | |
$4.19 | |
$4.28 | |
$3.97 | |
$4.20 | |
47.71K | |
257.73K | |
-- | |
$7.75 | |
$2.90 | |
-- | |
-- |
CAMP4 Therapeutics Corporation (CAMP) is trading at $4.13 in after-hours trading as of 2026-11-12 21:11:00, unchanged from the regular-session close of $4.13.
After-hours trading shows how investors are pricing CAMP after the regular session closes. The current after-hours price is near the regular-session close, indicating neutral after-hours sentiment.
Over the past seven days, CAMP4 Therapeutics Corporation (CAMP) moved from $3.83 to $4.13, representing a gain of 7.83% ($0.30).
The stock traded between $3.54 and $4.97 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 165.67 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 25.4%
CAMP is currently trading at $4.13, placing it 25.4% of the way from its 52-week low of $2.90 to its 52-week high of $7.75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 48 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for CAMP4 Therapeutics Corporation.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of CAMP4 Therapeutics Corporation (CAMP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CAMP, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CAMP shares and USD.
CAMP Shares to USD
1.00 CAMP shares = 4.13 USD
Calculations are estimates based on the latest available price and are for reference only.